Dappl Vaccine

Verify with FDA CVM →

48 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
48
Total Reports
10
Deaths Reported
2080.0%
Death Rate

Active Ingredients

Dappl Vaccine

Administration Routes

SubcutaneousUnknown

Species Affected

Dog 48

Most Affected Breeds

Chihuahua 8
Terrier - Yorkshire 4
Crossbred Canine/dog 4
Retriever - Labrador 3
Retriever - Golden 3
Terrier - Bull - American Pit 3
Dachshund (unspecified) 2
Shepherd Dog - Australian 2
Bulldog - French 2
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 2

Most Reported Reactions

Vomiting 20
Lethargy (see also Central nervous system depression in Neurological) 15
Diarrhoea 10
Anaphylaxis 9
Seizure NOS 9
Death by euthanasia 7
Pale mucous membrane 6
Elevated alanine aminotransferase (ALT) 5
Facial swelling (see also Skin) 4
Decreased appetite 3
Anaemia NOS 3
Lateral recumbency 3

Outcome Breakdown

Recovered/Normal
18 (37.5%)
Ongoing
17 (35.4%)
Euthanized
6 (12.5%)
Died
4 (8.3%)
Outcome Unknown
3 (6.3%)

Data Summary

Metric Value
Total adverse event reports 48
Reports involving death 10
Case-fatality rate (reported events) 2080.0%
Distinct species in reports 1
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Dappl Vaccine Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 48 adverse event reports referencing Dappl Vaccine, including 10 reports in which the animal died — a 2080.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Dappl Vaccine. Reported administration routes include Subcutaneous, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Dappl Vaccine reports are Dog (48 reports), with Dog accounting for the largest share. Within those species, Chihuahua (8), Terrier - Yorkshire (4), Crossbred Canine/dog (4) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Dappl Vaccine are Vomiting (20), Lethargy (see also Central nervous system depression in Neurological) (15), Diarrhoea (10), Anaphylaxis (9). Of the 48 reports with a coded outcome, Recovered/Normal is the leading category at 37.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Dappl Vaccine.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial